8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Malfunction of an MRI-Conditional Pacemaker Following an MRI

      case-report
      , PA-C, , MD, , MD, FHRS *
      HeartRhythm Case Reports
      Elsevier
      Pacemaker, MRI, MRI-conditional pacemaker, Malfunction

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction KEY TEACHING POINTS Key TeachinAU: Please review Key Teaching Points; the last 2 have been reworded to be summaries of what is learned from the case, rather than “action items”—OK as edited?g Points • All cardiac implantable electronic devices (CIEDs) merit complete evaluation following magnetic resonance imaging (MRI) scans, regardless of whether or not they have been labeled as MRI conditional. • It is important to recognize abnormal device parameters in CIEDs following exposure to an MRI environment. • It is important to understand the potential effects an MRI can have on CIEDs, even if they are labeled as MRI conditional. Patients with cardiac implantable electronic devices were historically unable to undergo magnetic resonance imaging (MRI). 1 In 2011 the Food and Drug Administration approved the first MRI conditional pacemaker system, the Revo MRI SureScan (Medtronic, Mounds View, MN). As per manufacturer recommendations, the Revo and other MRI conditional systems should be interrogated immediately before the MRI scan to activate the “SureScan” setting and immediately after the scan to confirm appropriate device function and enable restoration of pre-MRI settings. 2 MRI conditional pacemakers are specifically designed to minimize the risk of malfunction in the MRI environment. We report a case of an MRI conditional pacemaker system that malfunctioned at the time of an MRI scan and required a premature generator change procedure. Case Report A 63-year-old man underwent implant of a Revo MRI RVDR01 dual-chamber pacemaker with model 5086 leads on May 11, 2011 at an outside hospital for complete heart block. He was admitted to our institution on February 25, 2015 for a noncardiac condition. When his pacemaker was interrogated on admission, the device reported “Date of Visit” as April 8, 1996 (08-Apr-1996). However, the reported date of implant of May 11, 2011 11-May-2011 remained correct (Figure 1). The OBSERVATIONS section reported “MRI SureScan On: 16-Jan-1996 MRI SureScan Off: 16-Jan-1996. Data was not collected during MRI SureScan” (Figure 2). By the device clock, this event was 83 days prior to admission. Device information, including battery and lead measurements, lead trends, histograms, and arrhythmia data, was reported between May 1994 and April 1996 (Figure 3). Sensing, battery and lead impedances, and capture thresholds were within normal limits, and fluoroscopy of the system did not show any abnormalities (Figure 4). Review of outside records revealed that the patient underwent a brain MRI in a 1.5 T scanner 83 days prior to admission (Figure 5). The MRI was performed as per the MRI SureScan guidelines provided by Medtronic with maximum spatial gradient of <20 T/m (2000 G/cm), maximum gradient slew rate performance per axis of <200 T/m/s, and head specific absorption rate <3.2 W/kg. 2 As the patient was pacemaker dependent and the stability of the device could not be guaranteed, Medtronic technical support recommended generator replacement. The patient underwent removal of his Revo pulse generator and implant of a Medtronic Advisa DR MRI SureScan A2DR01. He did well post generator change and had no further abnormalities noted with his pacing system. The pacemaker pulse generator was returned to Medtronic for analysis. Destructive analysis revealed “There was no evidence of a device malfunction that would account for the power-on resets (PORs). No hybrid-related anomalies were found. Generation of a POR during analysis was unsuccessful and the root cause as to the reported events was unable to be determined.” Discussion We present a pacemaker-dependent patient with a Medtronic Revo MR Conditional Pacemaker that suffered a POR with subsequent malfunction of the device clock after a 1.5 T brain MRI. Such abnormal device behavior following exposure to the MRI environment has not been observed among non–MRI conditional devices in greater than 5000 reported scans and calls into question the durability of MRI-conditional devices in the MRI environment.3, 4, 5 Although patients with “legacy devices” (ie, those not labeled “MRI conditional”) can be scanned safely on a research basis under institutional review board–approved protocols, cardiac monitoring is required during the scan. 6 A major impetus for the development of MRI-conditional devices was that the performance of legacy devices in the MRI setting was not established. Theoretical complications of scanning legacy devices can include heating of the lead, movement of the device, and software or hardware malfunction. 7 Devices labeled as MRI conditional have presumably minimized the risk of these complications through reductions in ferrous content and have undergone extensive in vitro and in vivo testing prior to Food and Drug Administration approval.8, 9 Nevertheless, concerns remain that these devices could be susceptible to the MRI environment and they have been branded as “MRI conditional” (rather than “MRI safe”). Additionally, MRI-conditional pulse generators are based on earlier platforms, their leads are more prone to dislodgment and perforation,10, 11 and they are more expensive (in most settings) as compared with legacy devices. We believe this is the first reported incidence of an MRI-conditional device that did not tolerate the MRI environment. Despite the implausible “Date of Visit” and reported device parameter dates, the accurate date of implant recorded by the device argues against a primary date entry error at the time of implantation. Furthermore, it should be noted that the antecedent brain MRI scan was performed within Medtronic guidelines for safe MRI exposure. Although we cannot definitively exclude exposure to alternative energy sources that may have affected device performance, the fact that the SureScan activation and the brain MRI were both 83 days prior to interrogation strongly suggests the MRI was responsible for the abnormalities. Though the generator still appeared to function properly, the change of dates could not be clearly explained. In light of the patient’s pacemaker dependency and recommendations from the device manufacturer, generator replacement was performed. Given the added expense and decreased functionality of MRI-conditional devices, the risks and benefits of using these devices should be carefully considered going forward.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.

          Magnetic resonance imaging (MRI) is avoided in most patients with implanted cardiac devices because of safety concerns. To define the safety of a protocol for MRI at the commonly used magnetic strength of 1.5 T in patients with implanted cardiac devices. Prospective nonrandomized trial. (ClinicalTrials.gov registration number: NCT01130896) SETTING: One center in the United States (94% of examinations) and one in Israel. 438 patients with devices (54% with pacemakers and 46% with defibrillators) who underwent 555 MRI studies. Pacing mode was changed to asynchronous for pacemaker-dependent patients and to demand for others. Tachyarrhythmia functions were disabled. Blood pressure, electrocardiography, oximetry, and symptoms were monitored by a nurse with experience in cardiac life support and device programming who had immediate backup from an electrophysiologist. Activation or inhibition of pacing, symptoms, and device variables. In 3 patients (0.7% [95% CI, 0% to 1.5%]), the device reverted to a transient back-up programming mode without long-term effects. Right ventricular (RV) sensing (median change, 0 mV [interquartile range {IQR}, -0.7 to 0 V]) and atrial and right and left ventricular lead impedances (median change, -2 Ω [IQR, -13 to 0 Ω], -4 Ω [IQR, -16 to 0 Ω], and -11 Ω [IQR, -40 to 0 Ω], respectively) were reduced immediately after MRI. At long-term follow-up (61% of patients), decreased RV sensing (median, 0 mV, [IQR, -1.1 to 0.3 mV]), decreased RV lead impedance (median, -3 Ω, [IQR, -29 to 15 Ω]), increased RV capture threshold (median, 0 V, IQR, [0 to 0.2 Ω]), and decreased battery voltage (median, -0.01 V, IQR, -0.04 to 0 V) were noted. The observed changes did not require device revision or reprogramming. Not all available cardiac devices have been tested. Long-term in-person or telephone follow-up was unavailable in 43 patients (10%), and some data were missing. Those with missing long-term capture threshold data had higher baseline right atrial and right ventricular capture thresholds and were more likely to have undergone thoracic imaging. Defibrillation threshold testing and random assignment to a control group were not performed. With appropriate precautions, MRI can be done safely in patients with selected cardiac devices. Because changes in device variables and programming may occur, electrophysiologic monitoring during MRI is essential.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment.

            Magnetic resonance imaging (MRI) of pacemaker patients is contraindicated due to documented potential risks to the patient from hazardous interactions between the MRI and pacemaker system. The purpose of this prospective, randomized, controlled, worldwide clinical trial was to evaluate the safety and effectiveness of a pacemaker system designed for safe use in MRI for any bradycardia indicated patient. Patients (n = 464) were randomized to undergo an MRI scan between 9 and 12 weeks postimplant (MRI group, n = 258) or not to undergo MRI (control group, n = 206) after successful implantation of the specially designed dual-chamber pacemaker and leads. Patients were monitored for arrhythmias, symptoms, and pacemaker system function during 14 nonclinically indicated relevant brain and lumbar MRI sequences. Sequences were performed at 1.5 T and included scans with high radiofrequency power deposition and/or high gradient dB/dt exposure. Clinical evaluation of the pacemaker system function occurred immediately before and after MRI, 1 week and 1 month post-MRI, and at corresponding times for the control group. Primary endpoints for safety analyzed the MRI procedure complication-free rate and for effectiveness compared capture and sensing performance between MRI and control groups. No MRI-related complications occurred during or after MRI, including sustained ventricular arrhythmias, pacemaker inhibition or output failures, electrical resets, or other pacemaker malfunctions. Pacing capture threshold and sensed electrogram amplitude changes were minimal and similar between study groups. This trial documented the ability of this pacemaker system to be exposed in a controlled fashion to MRI in a 1.5 T scanner without adverse impact on patient outcomes or pacemaker system function. Copyright © 2011 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              American College of Radiology White Paper on MR Safety.

                Bookmark

                Author and article information

                Contributors
                Journal
                HeartRhythm Case Rep
                HeartRhythm Case Rep
                HeartRhythm Case Reports
                Elsevier
                2214-0271
                16 December 2016
                February 2017
                16 December 2016
                : 3
                : 2
                : 148-150
                Affiliations
                [0005]Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon
                Author notes
                [* ] Address reprint requests and correspondence: Dr Charles Henrikson, Director, Electrophysiology Service, Knight Cardiovascular Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, UHN 62, Portland, OR 97239.Knight Cardiovascular Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, UHN 62PortlandOR97239 henrikso@ 123456ohsu.edu
                Article
                S2214-0271(16)30139-7
                10.1016/j.hrcr.2016.11.007
                5420058
                7344ec93-3a66-4202-ba39-66562eb97c16
                © 2016 Heart Rhythm Society. Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Case Report

                pacemaker,mri,mri-conditional pacemaker,malfunction
                pacemaker, mri, mri-conditional pacemaker, malfunction

                Comments

                Comment on this article